PTPRD and urinary bladder carcinoma: Base on a public cohort, we analyzed the predictive efficiency of PTPRD mutation in other cancer types, including colorectal cancer, bladder cancer, head and neck cancer, esophagogastric cancer, melanoma, and unknown primary cancers.